Greenleaf Trust’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,210
| Closed | -$396K | – | 839 |
|
|
2024
Q4 | $396K | Buy |
1,210
+156
| +15% | +$51.1K | ﹤0.01% | 567 |
|
|
2024
Q3 | $316K | Sell |
1,054
-22
| -2% | -$6.6K | ﹤0.01% | 647 |
|
|
2024
Q2 | $354K | Sell |
1,076
-84
| -7% | -$27.7K | ﹤0.01% | 568 |
|
|
2024
Q1 | $459K | Buy |
1,160
+7
| +0.6% | +$2.77K | ﹤0.01% | 497 |
|
|
2023
Q4 | $406K | Sell |
1,153
-386
| -25% | -$136K | ﹤0.01% | 521 |
|
|
2023
Q3 | $577K | Sell |
1,539
-32
| -2% | -$12K | 0.01% | 393 |
|
|
2023
Q2 | $601K | Buy |
1,571
+15
| +1% | +$5.74K | 0.01% | 409 |
|
|
2023
Q1 | $539K | Buy |
1,556
+307
| +25% | +$106K | 0.01% | 430 |
|
|
2022
Q4 | $294K | Buy |
1,249
+108
| +9% | +$25.4K | ﹤0.01% | 588 |
|
|
2022
Q3 | $281K | Sell |
1,141
-133
| -10% | -$32.8K | ﹤0.01% | 563 |
|
|
2022
Q2 | $385K | Sell |
1,274
-1
| -0.1% | -$302 | 0.01% | 482 |
|
|
2022
Q1 | $524K | Sell |
1,275
-1
| -0.1% | -$411 | 0.01% | 403 |
|
|
2021
Q4 | $598K | Buy |
1,276
+5
| +0.4% | +$2.34K | 0.01% | 369 |
|
|
2021
Q3 | $540K | Buy |
1,271
+61
| +5% | +$25.9K | 0.01% | 366 |
|
|
2021
Q2 | $435K | Sell |
1,210
-782
| -39% | -$281K | 0.01% | 439 |
|
|
2021
Q1 | $561K | Buy |
1,992
+128
| +7% | +$36K | 0.01% | 344 |
|
|
2020
Q4 | $528K | Buy |
1,864
+14
| +0.8% | +$3.97K | 0.01% | 319 |
|
|
2020
Q3 | $509K | Buy |
1,850
+873
| +89% | +$240K | 0.01% | 280 |
|
|
2020
Q2 | $222K | Buy |
+977
| New | +$222K | ﹤0.01% | 481 |
|
|
2018
Q2 | – | Sell |
-349
| Closed | -$31K | – | 589 |
|
|
2018
Q1 | $31K | Hold |
349
| – | – | ﹤0.01% | 500 |
|
|
2017
Q4 | $34K | Hold |
349
| – | – | ﹤0.01% | 520 |
|
|
2017
Q3 | $34K | Buy |
+349
| New | +$34K | ﹤0.01% | 487 |
|